CRISPR Therapeutics AG
(NASDAQ : CRSP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 4.33%154.810.0%$1863.66m
NVAXNovavax, Inc. 4.39%231.2392.9%$1423.06m
OCGNOcugen, Inc. 36.88%10.950.0%$1213.37m
AMGNAmgen, Inc. -1.14%224.921.3%$594.80m
ILMNIllumina, Inc. -1.45%439.413.5%$530.13m
REGNRegeneron Pharmaceuticals, Inc. -0.58%450.572.7%$522.91m
VRTXVertex Pharmaceuticals, Inc. -0.20%212.551.9%$515.41m
GILDGilead Sciences, Inc. -2.21%61.401.0%$485.52m
BIIBBiogen, Inc. -1.58%272.881.7%$380.18m
BNGOBioNano Genomics, Inc. -2.89%9.730.0%$374.38m
ALXNAlexion Pharmaceuticals, Inc. -0.59%152.752.0%$371.25m
CRSPCRISPR Therapeutics AG -1.25%125.690.6%$292.02m
EXASEXACT Sciences Corp. 3.67%136.1218.4%$252.07m
SGENSeagen Inc. 0.68%151.115.8%$212.33m
VXRTVaxart, Inc. -4.67%7.150.0%$210.57m

Company Profile

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.